Ashaye A, Shi L, Aldoss I, Montesinos P, et al. Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial. Leukemia 2025 Apr 16. doi: 10.1038/s41375-025-02608.
PMID: 40240572